在癌症免疫中常规的1型树突细胞 (cDC1)
Peng Liu1,2, Liwei Zhao1,2, Guido Kroemer3,4,5
1Centre de Recherche des Cordeliers, Equipe Labellisée par la Ligue Contre le Cancer, Université de Paris Cité, Inserm U1138, Institut Universitaire de France, Sorbonne Université, 75006, Paris, France.
Biology direct
|November 1, 2023
概括
癌症免疫疗法利用树突细胞 (DC) 来对抗瘤. 传统的1型树突细胞 (cDC1) 对于激活抗癌免疫反应至关重要,为新疗法显示出希望.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
背景情况:
- 癌症免疫疗法已经改变了癌症治疗.
- 树突细胞 (DC) 是抗瘤免疫的核心.
- 传统的1型树突细胞 (cDC1) 对于启动抗癌免疫反应至关重要.
研究的目的:
- 审查cDC1.1的特性.
- 突出cDC1在抗癌免疫中的作用.
- 探索基于cDC1的免疫疗法策略.
主要方法:
- 关于cDC1生物学和功能的文献综述.
- 分析cDC1在抗原呈现和T细胞激活中的作用.
- 基于cDC1的当前和潜在治疗方法的综合.
主要成果:
- cDC1具有独特的抗原交叉呈现能力.
- cDC1对于启动细胞毒性T淋巴细胞对瘤的反应至关重要.
- 基于cDC1的策略为癌症免疫治疗提供了一个有希望的途径.
结论:
- cDC1是抗瘤免疫的关键调节者.
- 了解cDC1生物学对于开发有效的癌症免疫疗法至关重要.
- 向cDC1在瘤学中具有显著的治疗潜力.
相关概念视频
Cell-mediated Immune Responses
68.6K
Overview
68.6K
T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
Cytotoxic T Cells-mediated Immune Response
928
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
928
Cancer Vaccines
380
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
380
T Cell Activation and Clonal Selection
753
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
753
Antigens Involved in Adaptive Immunity
507
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
507


